DrugPatentWatch Database Preview
Details for Patent: 9,242,986
» See Plans and Pricing
Which drugs does patent 9,242,986 protect, and when does it expire?
Patent 9,242,986 protects TIVICAY PD, DOVATO, JULUCA, TIVICAY, and TRIUMEQ, and is included in five NDAs.
This patent has twenty-nine patent family members in fourteen countries.
Summary for Patent: 9,242,986
Title: | Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates |
Abstract: | A synthesis approach providing an early ring attachment via a bromination to compound 1-1 yielding compound II-II, whereby a final product such as AA can be synthesized. In particular, the 2,4-difluorophenyl-containing sidechain is attached before creation of the additional ring Q. ##STR00001## |
Inventor(s): | Kawasuji; Takashi (Osaka, JP), Nagamatsu; Daiki (Osaka, JP) |
Assignee: | SHIONOGI & CO., LTD. (Osaka, JP) ViiV Healthcare Company (Research Triangle Park, NC) |
Application Number: | 14/272,823 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,242,986 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 9,242,986
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Viiv Hlthcare | TIVICAY PD | dolutegravir sodium | TABLET, FOR SUSPENSION;ORAL | 213983-001 | Jun 12, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | |||
Viiv Hlthcare | DOVATO | dolutegravir sodium; lamivudine | TABLET;ORAL | 211994-001 | Apr 8, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | |||
Viiv Hlthcare | JULUCA | dolutegravir sodium; rilpivirine hydrochloride | TABLET;ORAL | 210192-001 | Nov 21, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,242,986
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2009325128 | Start Trial | |||
Brazil | PI0923217 | Start Trial | |||
Canada | 2744019 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |